Jeff Wells

October 10, 2020

Comments Off on Jeff Wells

Mr. Jeff Wells has over 25 years of CMC-related experience in vaccines, gene therapy, pharmaceuticals, and the medical devices industry. His functional experience ranges from development and day-to-day management of QA/QC operations to remediating quality systems at firms of various sizes. Mr. Wells has held various quality management positions at Baxter Healthcare Corp and other […]

Stephen Johnson

October 10, 2020

Comments Off on Stephen Johnson

Mr. Stephen Johnson has over thirteen years of experience in the pharmaceutical industry. He was previously the Filling and Formulation Manager at CAMRIS, the Formulation and Fill Manager at Walter Reed Army Institute of Research and Production Supervisor, Sterile Products at United Therapeutics. Mr. Johnson is skilled in GxP, quality control systems, barrier isolator systems, […]

Michael Billard

October 10, 2020

Comments Off on Michael Billard

Mr. Michael Billard came to APT in September 2020 following a twenty-year career in biotech, pharma, and consumer product development. He has held senior leadership roles at Propella Therapeutics, Inc., Vizuri Health Sciences, Paragon Bioservices, and DSM Nutritional Products (formerly Martek BioSciences) along with project management positions at MedImmune, Inc. and Baxter Healthcare Corporation. Mr. […]

Jarrar Haider

October 10, 2020

Comments Off on Jarrar Haider

Mr. Jarrar Haider was previously a senior molecular biologist at the Genome Research Center. After completing his Bachelor of Science in Chemistry and Biology at Bahauddin Zakariya University and his Master of Science in Molecular Biology and Biotechnology at the University of Lahore, he was a lecturer at BZU. Mr. Haider has continued his education […]

Joe Fackler

October 10, 2020

Comments Off on Joe Fackler

Mr. Joseph Fackler has played a key role in the design and development of GMP compliant manufacturing methods for the production and purification of bacteriophages to be included in APT’s PhageBank. Mr. Fackler’s prior research focused on virus-host interactions which included investigation into mechanisms for host-cell resistance to infection and virus countermeasures to overcome resistance. […]